Sino Biopharmaceutical Ltd Financials

Market Capitalization HK$126.15 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	26.50
Forward PE	22.10
Price to Sales TTM	HK$3.72
Price to Book MRQ	HK$3.06
Enterprise to Revenue	3.87
Enterprise to EBITDA	17.19

Financial Reports as of Jun. 30, 2021

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2021-06-30
Profit Margin	12.67%
Operating Margin	19.39%
Return on Assets TTM	5.07%
Return on Equity TTM	15.41%

Income Statement

Revenue TTM	HK$33,989,373,498
Revenue per Share TTM	HK$1.69
Quarterly Revenue Growth	10.70%
Gross Profit TTM	HK$27,792,840,503
EBITDA	HK$13,205,607,000
Net Income to Common TTM	HK$4,334,382,322
Diluted EPS TTM	HK$0.24
Quarterly Earnings Growth YoY	12.30%

Balance Sheet

Total Cash MRQ	HK$22,043,118,364
Total Cash per Share MRQ	HK$1.11
Total Debt MRQ	HK$
Total Debt to Equity MRQ	26.12
Current Ratio MRQ	1.36
Book Value per Share MRQ	HK$2.08

Cash Flow

Operating Cash Flow TTM	HK$7,447,016,527
Levered Free Cash Flow TTM	HK$4,660,904,058

1177 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	17,885,721,987
Float Shares	8,802,100,361
Avg 10 Volume	48,381,634
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.39%
% Held by Institutions	16.61%

Stock Price Summary

Beta	0.83
Fifty Two Week Low	HK$2.67
Fifty Two Week High	HK$9.12
Fifty Two Week Change	51.89%
Day 50 MA	HK$6.82
Day 200 MA	HK$6.18

Dividends and Splits

Forward Annual Dividend Rate	HK$0.10
Forward Annual Dividend Yield	1.57%
Trailing Annual Dividend Rate	HK$0.09
Trailing Annual Dividend Yield	1.42%
Payout Ratio	29.41%
Dividend Date
Ex Dividend Date	2025-08-29
Last Split Factor
Last Split Date	2020-07-20